Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended on March 31, 2025.
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India reported strong audited results for the fourth quarter and full year ended March 31, 2025. Total income from operations for FY25 grew about 9.6% to ₹6,684.73 crore from ₹6,097.18 crore in FY24. Q4 FY25 revenue rose to ₹1,680.61 crore from ₹1,519.78 crore in Q4 FY24, a 10.6% increase. Net profit after tax for FY25 jumped 17.7% to ₹1,414.44 crore from ₹1,201.22 crore, while Q4 FY25 net profit surged 27.9% to ₹367.04 crore from ₹287.06 crore. Basic earnings per share for the full year stood at ₹665.62 versus ₹565.28 in the previous year, a 17.7% rise. The Q4 figures are balancing figures derived from audited annual numbers and previously reviewed nine-month results.
Strong double-digit profit growth and healthy revenue expansion signal robust operational performance, which is positive for shareholders. The improved EPS reflects enhanced value creation, though the stock reaction will depend on whether these results were already anticipated by the market.